CellCarta
Board
5 directors, 1 in day-to-day management, 1 auditor, last change in May 2026Director
since 06-02-2025
term until 08-05-2030
listed in the 2025 annual accounts, filed on 09-06-2026
Miller Elliot
Director
since 08-07-2025
term until 14-05-2031
listed in the 2025 annual accounts, filed on 09-06-2026
Hendriks Consulting Company BV
Director, permanent representative Dirk Hendriks
since 11-09-2025
term until 14-05-2031
listed in the 2025 annual accounts, filed on 09-06-2026
Roel Boons BV
Statutory auditor, permanent representative Roel Boons
appointed by deed of 11-08-2026
- Kristien Verhoeven
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 12-01-2026
Permanent representatives 1
Dirk Hendriks
Permanent representative, for Hendriks Consulting Company BV
in office according to the deed of 07-02-2022
Mandates through the years
13 names, the dashed line is todayHendriks Consulting Company BV
Director
Director
Maurice Tenney III
Director
Director
Joshua Schultz
Director
Director
Miller Elliot
Director
Director
Elliott Miller
Director
Director
Kristien Verhoeven
Day-to-day manager
Day-to-day manager
Roel Boons BV
Statutory auditor
Statutory auditor
BDO Bedrijfsrevisoren CVBA
Statutory auditor
Statutory auditor
BV PwC Bedrijfsrevisoren
Statutory auditor
Statutory auditor
Kockx-Consulting BVBA
Director
Director
Anthony L. Mattacchione
Director
Director
David Spaight
Director
Director
Martin LeBlanc
Managing director
Managing director
LeadershipBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
- Hendriks Consulting Company BV
- Director, from 06-05-2019 to date
- Maurice Tenney III
- Director, appointed by deed of 06-12-2023, still in office
- Joshua Schultz
- Director, since before 31-12-2024
- Miller Elliot
- Director, since before 31-12-2024
- Elliott Miller
- Director, appointed by deed of 12-01-2026, still in office
- Kristien Verhoeven
- Day-to-day manager, appointed by deed of 06-12-2023, still in office
- Roel Boons BV
- Statutory auditor, appointed by deed of 11-08-2026, still in office
- BDO Bedrijfsrevisoren CVBA
- Statutory auditor, from 12-05-2021 to 11-08-2026
- BV PwC Bedrijfsrevisoren
- Statutory auditor, from before 31-12-2022 to 11-08-2026
- Kockx-Consulting BVBA
- Director, from 06-05-2019 to 11-03-2026
- Anthony L. Mattacchione
- Director, from before 31-12-2021 to 30-06-2025
- David Spaight
- Director, from 01-08-2019 to 06-02-2025
- Martin LeBlanc
- Director, from 01-08-2019 to 30-08-2023
- Managing director, until 30-08-2023
Control
83.3%
This company
CellCarta
Equity €25.9m
Profit €7.7m in 2025
Further up the chainArsenal IO Belgium 100%Arsenal IO Canada 3 CA consolidates
Capital
- Capital
- €1,062,000
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- HistoGeneX Holding
- Arsenal IO Canada 3
- Own shares
Source: shareholder structure in its own accounts, parent in its own accounts
Articles of association
deed of 11-08-2026 (in Dutch)- Power of attorneyA power of attorney lets someone perform specific acts on the company's behalf.
- “Stanko Radoman”“Sacha Szmir”“Maxime Wève”“Frédérique Bielen”
Shareholders
2 ownersOwners 2
- HistoGeneX HoldingparentEquity €65.9m Profit of €24,715 in 2025 (profit of €117,553 in 2024)83.3%
- Arsenal IO Canada 3CAconsolidating parentconsolidates
Own shares 16.7% Source own accounts 2025